Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib‐Treated Patients With Gastrointestinal Stromal Tumors...

Por Schindler, E, Krishnan, SM, Mathijssen, RHJ, Ruggiero, A, Schiavon, G, Friberg, LE
Publicado no CPT Pharmacometrics Syst Pharmacol (2017)

Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial

Por Hrebien, S, Citi, V, Garcia-Murillas, I, Cutts, R, Fenwick, K, Kozarewa, I, McEwen, R, Ratnayake, J, Maudsley, R, Carr, T H, de Bruin, E C, Schiavon, G, Oliveira, M, Turner, N
Publicado no Ann Oncol (2019)

BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrog...

Por Turner, N C, Alarcón, E, Armstrong, A C, Philco, M, López Chuken, Y A, Sablin, M -P, Tamura, K, Gómez Villanueva, A, Pérez-Fidalgo, J A, Cheung, S Y A, Corcoran, C, Cullberg, M, Davies, B R, de Bruin, E C, Foxley, A, Lindemann, J P O, Maudsley, R, Moschetta, M, Outhwaite, E, Pass, M, Rugman, P, Schiavon, G, Oliveira, M
Publicado no Ann Oncol (2019)